NEW YORK (Dow Jones)--The U.S. Food and Drug Administration has rejected a spine device from Medtronic Inc. (MDT), a setback that comes amid outside concerns regarding whether an ingredient used in the product might be linked to cancer.
NEW YORK (Dow Jones)--The U.S. Food and Drug Administration has rejected a spine device from Medtronic Inc. (MDT), a setback that comes amid outside concerns regarding whether an ingredient used in the product might be linked to cancer.
